Loading…
2 companies · GEL, thousands · columns ordered by revenue
GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series
| Metric | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 32,245 | 34,068 | 36,441 | 28,087 | 53,778 | 53,529 | 32,475 | 52,368 |
| EBITDA | 7,117 | 4,538 | 5,991 | 4,565 | 6,706 | 6,532 | 4,482 | 5,149 |
| Net profit | 5,991 | 4,446 | 4,525 | 4,733 | 5,705 | 5,173 | 3,530 | 3,924 |
| Total assets | 27,934 | 33,675 | 31,375 | 32,265 | 53,231 | 41,306 | 43,648 | 46,594 |
| n (companies reporting) | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
GEL, thousands
| Company | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|---|
| Advanced Medical Techno… | 32,245 | 34,068 | 36,441 | 28,087 | 53,778 | 51,860 | 30,736 | 50,081 |
| Gionik Group | — | — | — | — | 0 | 1,669 | 1,739 | 2,287 |
Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.
Peer coverage varies by year — FY2017–FY2021 pool fewer than the 2 picked companies (see the n row). A year is never dropped because one peer is missing.
Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.